BCDA
Price
$0.38
Change
+$0.02 (+5.56%)
Updated
Apr 18, 6:59 PM EST
20 days until earnings call
CTCX
Price
$2.07
Change
+$0.01 (+0.49%)
Updated
Apr 18, 6:59 PM EST
Ad is loading...

Compare trend and price BCDA vs CTCX

Header iconBCDA vs CTCX Comparison
Open Charts BCDA vs CTCXBanner chart's image
BioCardia
Price$0.38
Change+$0.02 (+5.56%)
Volume$41.93K
CapitalizationN/A
Carmell
Price$2.07
Change+$0.01 (+0.49%)
Volume$303
CapitalizationN/A
View a ticker or compare two or three
BCDA vs CTCX Comparison Chart

Loading...

BCDADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCDA vs. CTCX commentary
Apr 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a StrongSell and CTCX is a Hold.

COMPARISON
Comparison
Apr 19, 2024
Stock price -- (BCDA: $0.37 vs. CTCX: $2.20)
Brand notoriety: BCDA and CTCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 8% vs. CTCX: 91%
Market capitalization -- BCDA: $9.89M vs. CTCX: $42.34M
BCDA [@Biotechnology] is valued at $9.89M. CTCX’s [@Biotechnology] market capitalization is $42.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $551.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green whileCTCX’s FA Score has 1 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • CTCX’s FA Score: 1 green, 4 red.
According to our system of comparison, CTCX is a better buy in the long-term than BCDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 3 TA indicator(s) are bullish.

  • BCDA’s TA Score: 3 bullish, 4 bearish.

Price Growth

BCDA (@Biotechnology) experienced а -7.98% price change this week, while CTCX (@Biotechnology) price change was -15.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.57%. For the same industry, the average monthly price growth was -2.16%, and the average quarterly price growth was +1228.07%.

Reported Earning Dates

BCDA is expected to report earnings on Aug 07, 2024.

CTCX is expected to report earnings on Mar 17, 2023.

Industries' Descriptions

@Biotechnology (-7.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCDA with price predictions.
OPEN
A.I.dvisor published
a Summary for CTCX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CTCX($42.3M) has a higher market cap than BCDA($9.89M). CTCX YTD gains are higher at: -42.257 vs. BCDA (-44.580).
BCDACTCXBCDA / CTCX
Capitalization9.89M42.3M23%
EBITDAN/AN/A-
Gain YTD-44.580-42.257105%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
BCDA: Fundamental Ratings
BCDA
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCDA
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
BCDADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRIO1.210.04
+3.42%
DarioHealth Corp
GWRS12.12N/A
N/A
Global Water Resources
CEG185.40-1.25
-0.67%
Constellation Energy Corp
PDFS31.28-0.65
-2.04%
PDF Solutions
DOOO69.61-2.41
-3.35%
BRP

BCDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCDA has been loosely correlated with LABP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BCDA jumps, then LABP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCDA
1D Price
Change %
BCDA100%
+1.07%
LABP - BCDA
35%
Loosely correlated
+0.70%
LYEL - BCDA
30%
Poorly correlated
-1.24%
MDGL - BCDA
29%
Poorly correlated
-1.99%
INO - BCDA
28%
Poorly correlated
+14.89%
STOK - BCDA
28%
Poorly correlated
-5.86%
More

CTCX and

Correlation & Price change

A.I.dvisor tells us that CTCX and URGN have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTCX and URGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTCX
1D Price
Change %
CTCX100%
N/A
URGN - CTCX
23%
Poorly correlated
-1.73%
VRCA - CTCX
22%
Poorly correlated
+0.86%
BCDA - CTCX
22%
Poorly correlated
+1.07%
RVMD - CTCX
20%
Poorly correlated
+1.57%
KOD - CTCX
20%
Poorly correlated
-7.46%
More